Prime editing system offers wide range of versatility in human cells, correcting disease-causing genetic variations
from The Harvard Gazette
A team from the Broad Institute of MIT and Harvard has developed a new CRISPR genome-editing approach that has the potential to correct up to 89% of known disease-causing genetic variations. Researchers have combined two of the most important proteins in molecular biology — CRISPR-Cas9 and a reverse transcriptase — into a single machine.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063